›
^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersTEST:FoundationOne® Heme CDx
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
RocheType:
Laboratory Developed Test
Related tests:
FoundationOne Heme is a laboratory developed CGP test combining DNA sequencing of 406 genes and RNA sequencing of 265 genes for patients with hematologic malignancies, sarcomas or solid tumors where RNA sequencing is desired. It detects the four main classes of genomic alterations for hematologic cancers, sarcomas, and solid tumors where RNA sequencing is desired.
Cancer:
Hematological Malignancies, Sarcoma, Solid Tumor
Gene:
ALK (Anaplastic lymphoma kinase), ASXL1 (ASXL Transcriptional Regulator 1), BCL2 (B-cell CLL/lymphoma 2), BRAF (B-raf proto-oncogene), BRCA1 (Breast cancer 1, early onset), BRCA2 (Breast cancer 2, early onset)
See More ...
ALK (Anaplastic lymphoma kinase), ASXL1 (ASXL Transcriptional Regulator 1), BCL2 (B-cell CLL/lymphoma 2), BRAF (B-raf proto-oncogene), BRCA1 (Breast cancer 1, early onset), BRCA2 (Breast cancer 2, early onset), CCND1 (Cyclin D1), CCND2 (Cyclin D2), CCND3 (Cyclin D3), CDK4 (Cyclin-dependent kinase 4), CDK6 (Cyclin-dependent kinase 6), CEBPA (CCAAT Enhancer Binding Protein Alpha), EGFR (Epidermal growth factor receptor), ERBB3 (V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 3), ERBB4 (erb-b2 receptor tyrosine kinase 4), FGFR1 (Fibroblast growth factor receptor 1), FGFR2 (Fibroblast growth factor receptor 2), FGFR3 (Fibroblast growth factor receptor 3), FGFR4 (Fibroblast growth factor receptor 4), FLT3 (Fms-related tyrosine kinase 3), HER-2 (Human epidermal growth factor receptor 2), IDH1 (Isocitrate dehydrogenase (NADP(+)) 1), IDH2 (Isocitrate Dehydrogenase (NADP(+)) 2), JAK1 (Janus Kinase 1), JAK2 (Janus kinase 2), KIT (KIT proto-oncogene, receptor tyrosine kinase), MSI (Microsatellite instability), NPM1 (Nucleophosmin 1), NTRK1 (Neurotrophic tyrosine kinase, receptor, type 1), PALB2 (Partner and localizer of BRCA2), PDGFRA (Platelet Derived Growth Factor Receptor Alpha), PDGFRB (Platelet Derived Growth Factor Receptor Beta), PTCH1 (Patched 1), PTEN (Phosphatase and tensin homolog), ROS1 (Proto-Oncogene Tyrosine-Protein Kinase ROS), SMAD4 (SMAD family member 4), STAT3 (Signal Transducer And Activator Of Transcription 3), STAT5B (Signal Transducer And Activator Of Transcription 5B), TMB (Tumor Mutational Burden), TP53 (Tumor protein P53), TSC1 (TSC complex subunit 1), TSC2 (TSC complex subunit 2), mTOR (Mechanistic target of rapamycin kinase)
Method:
Comprehensive Genomic Profiling
